亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Extensive Molecular Analysis Strongly Improves the Distinction Between AML and ALL in Adult Acute Leukemias of Ambiguous Lineage

CEBPA公司 净现值1 CDKN2A CDKN2B公司 髓样 免疫分型 白血病 生物 癌症研究 ETV6 免疫学 肿瘤科 医学 基因 抗原 遗传学 核型 染色体易位 突变 染色体
作者
Anikó Szabó,Mathijs A. Sanders,Carla Exalto,Jasper Koenders,Patricia G. Hoogeveen,Anita M. Schelen,Willemijn van den Ancker,Arjan A. van de Loosdrecht,Bob Löwenberg,Vincent H. J. van der Velden,Jan J. Cornelissen,Peter J.M. Valk,Anita W. Rijneveld
出处
期刊:Blood [Elsevier BV]
卷期号:124 (21): 1067-1067 被引量:1
标识
DOI:10.1182/blood.v124.21.1067.1067
摘要

Abstract Background In 1995 the European Group for the Immunological Classification of Leukemias (EGIL) presented guidelines to classify bilineage and biphenotypic acute leukemias (BAL). Subsequently, the WHO in 2008 defined mixed phenotype acute leukemias (MPAL), as leukemias coexpressing antigens of both lymphoid and myeloid lineage, and leukemias with distinct blast populations of more than one lineage. However, a classifying diagnosis towards myeloid or lymphoid leukemia based on an extensive molecular-biological characterization could provide much better distinction, which could be useful for selecting AML or ALL like treatment approaches. We investigated whether extensive molecular analysis might improve a diagnosis of BAL/MPAL into predominant AML or ALL. Patients and methods For this study 25 adults, diagnosed between 2000 and 2009 with BAL/MPAL were identified. Flowcytometry and cytogenetics were performed at diagnosis. In addition, molecular analysis was performed to identify BCR-ABL, MLL, AML1-ETO, CBF-MYH11, SIL-TAL1, SET-NUP, NUP-ABL fusion transcripts, FLT3-ITD, CEBPA, NPM1, NOTCH1 mutations and IKZF1, CDKN2A, CDKN2B deletions. Furthermore, multiplex PCR assays to detect immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements were performed. Gene expression profiles (GEP) were generated, and results were compared to an AML/ALL classifier profile. A classifying diagnosis of either ALL or AML was made if at least two of the 5 assays applied, were highly suggestive for a specific lineage without explicit contradicting results of the remaining assays. Results Twenty-four of the 25 BAL/MPAL cases could be diagnosed into predominant AML or ALL by extensive molecular analysis (Table 1). In 11 cases the WHO2008 criteria classified BAL cases as AML or ALL, and extensive molecular analysis also indicated the same lineage. Adding standard cytogenetic and molecular analysis improved the WHO classification in another 4 patients. Remarkably, extensive molecular analysis clearly showed preference for either AML or ALL in all of the MPAL cases. As a result, we were able to improve a diagnosis in all MPAL cases. Only 1 of the 25 patients remained unclassified. Statistical analysis did not show significant correlation between the different assays. Twelve patients received AML-based chemotherapy, including 3 patients ultimately classified as ALL. Moreover, among 12 patients who received ALL type therapy, 1 was retrospectively classified as AML. In general, outcome appeared very poor with a 3 year overall survival of 32% (Kaplan-Meier estimate, 95%CI: 14%-51%). Conclusions This study suggests that a differential diagnosis of AML versus ALL is partly improved by applying the WHO2008 criteria instead of the EGIL classification. However, extensive molecular analysis, including GEP and Ig/TCR, more strongly enabled the identification of the lineage of origin, ultimately resulting in a classifying diagnosis in 24 out of 25 patients. So far no assay appeared as golden standard but different complementary techniques showed additive value. Collectively these results strongly argue for advanced, centralized diagnostic procedures in patients with acute leukemia of ambiguous lineage, which may subsequently enable the development of specific therapeutic approaches in these poor-risk patients. Table 1 Patient characteristics Age (year) EGIL WHO 2008 Molecular aberrations GEP probability Ig/TCR Classification AML ALL 51 TM MPAL * 0,000 1,000 POS ALL 52 TM MPAL FLT3-ITD 0,970 0,030 NEG AML 20 BM MPAL MLL-AF4 CEBPA 0,000 1,000 POS ALL 18 BM MPAL IKZF1 CDKN2A-2B 0,000 1,000 POS ALL 49 BM MPAL BCR-ABL IKZF1 ND ND POS ALL 57 BM MPAL CDKN2A 0,000 1,000 POS ALL 40 BM MPAL CDKN2A-2B ND ND POS ALL 23 T MPAL CDKN2A ND ND POS ALL 24 B MPAL * 0,000 1,000 POS ALL 65 B MPAL BCR-ABL IKZF1 CDKN2A ND ND POS ALL 58 BM AML * 1,000 0,000 NEG AML 52 BM AML NPM1 ND ND NEG AML 59 BM AML FLT3-ITD NPM1 ND ND NEG AML 41 BM AML FLT3-ITD CEBPA NPM1 ND ND POS AML 69 BM AML MLL ND ND NEG AML 18 BM AML CBF-MYH11 ND ND POS AML 71 BM # FLT3-ITD CDKN2A-2B 0,709 0,291 NEG AML 67 BM # * 0,003 0,997 POS ALL 15 BM ALL IKZF1 CDKN2A-2B ND ND POS ALL 23 BM # * 0,998 0,002 POS ? 32 BTM # * 0,938 0,062 POS AML 27 BTM ALL IKZF1 0,001 0,999 POS ALL 69 BTM ALL CDKN2A-2B 0,098 0,902 NEG ALL 16 BTM ALL CDKN2A-2B ND ND POS ALL 54 TM ALL NOTCH1 0,148 0,852 NEG ALL # Unclear classification according to WHO2008 * No abnormalities Abbreviations: ND, not determined. Disclosures No relevant conflicts of interest to declare.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jianghs完成签到,获得积分10
7秒前
科目三应助11采纳,获得10
8秒前
jianghs发布了新的文献求助10
11秒前
14秒前
feifei完成签到,获得积分10
17秒前
feifei发布了新的文献求助10
19秒前
福娃哇完成签到 ,获得积分10
20秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
科目三应助科研通管家采纳,获得10
24秒前
24秒前
草莓熊1215完成签到 ,获得积分10
32秒前
青竹完成签到,获得积分10
34秒前
旺仔先生完成签到 ,获得积分10
49秒前
49秒前
candy teen完成签到,获得积分10
58秒前
垃圾桶完成签到 ,获得积分10
1分钟前
李健应助含蓄绿竹采纳,获得10
1分钟前
和谐的小松鼠完成签到,获得积分10
1分钟前
Oculus完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
含蓄绿竹发布了新的文献求助10
1分钟前
有机发布了新的文献求助10
1分钟前
俊逸沛菡完成签到 ,获得积分10
2分钟前
2分钟前
可靠雨文发布了新的文献求助10
2分钟前
噼里啪啦完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
Jasper应助科研通管家采纳,获得10
2分钟前
江小鱼在查文献完成签到,获得积分10
2分钟前
chen发布了新的文献求助10
2分钟前
123完成签到,获得积分10
2分钟前
fx完成签到 ,获得积分10
2分钟前
chen完成签到,获得积分10
2分钟前
ZYSNNNN完成签到,获得积分10
3分钟前
iiii完成签到,获得积分20
3分钟前
zhuanghj5完成签到,获得积分10
3分钟前
吴玉婷关注了科研通微信公众号
3分钟前
3分钟前
明昼完成签到,获得积分10
3分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990015
求助须知:如何正确求助?哪些是违规求助? 3532077
关于积分的说明 11256227
捐赠科研通 3270933
什么是DOI,文献DOI怎么找? 1805139
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228